Acro Biomedical (ACBM) Equity Average (2016 - 2025)
Acro Biomedical's quarterly Equity Average came in at -$409791.5 in Q4 2025, down 41.19% year-on-year from -$696824.1 in Q4 2024, and down 9.26% quarter-over-quarter from -$375069.5 in Q3 2025.
Acro Biomedical has reported Equity Average for 10 years, with the latest figure at -$409791.5 in Q4 2025.
- For the quarter ending Q4 2025, Equity Average fell 41.19% year-over-year to -$409791.5; the trailing twelve-month figure through Dec 2025 stood at -$409791.5 (down 41.19% YoY), and the FY2025 full-year result was -$340968.0, down 23.54% from the prior year.
- Equity Average for Q4 2025 stood at -$409791.5, down from -$375069.5 in the prior quarter.
- The five-year high for Equity Average was $657372.5 in Q1 2021, with the low at -$409791.5 in Q4 2025.
- Average Equity Average over 5 years is $145140.0, with a median of $212649.8 recorded in 2023.
- Year-over-year, Equity Average dropped 2.12% in 2022 and tumbled 661.67% in 2024.
- Tracing ACBM's Equity Average over 5 years: stood at $605962.5 in 2021, then fell by 19.26% to $489267.0 in 2022, then plunged by 150.75% to -$248313.5 in 2023, then dropped by 16.88% to -$290238.0 in 2024, then tumbled by 41.19% to -$409791.5 in 2025.
- The last three Equity Average figures came in at -$409791.5 (Q4 2025), -$375069.5 (Q3 2025), and -$310713.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | -16.34 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -11.95 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -13.69 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | -10.65 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -28.22 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -16.03 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | -8.00 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -13.60 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -8.01 Mn |
| 10 | Acro Biomedical | - | - | - | -409,791.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -409,791.50 |
| Sep 30, 2025 | -375,069.50 |
| Jun 30, 2025 | -310,713.00 |
| Mar 31, 2025 | -299,439.00 |
| Dec 31, 2024 | -290,238.00 |
| Sep 30, 2024 | -280,951.00 |
| Jun 30, 2024 | -271,855.00 |
| Mar 31, 2024 | -262,163.00 |
| Dec 31, 2023 | -248,313.50 |
| Sep 30, 2023 | 50,020.50 |
| Jun 30, 2023 | 375,279.00 |
| Mar 31, 2023 | 448,637.00 |
| Dec 31, 2022 | 489,267.00 |
| Sep 30, 2022 | 533,525.50 |
| Jun 30, 2022 | 609,053.00 |
| Mar 31, 2022 | 643,463.00 |
| Dec 31, 2021 | 605,962.50 |
| Sep 30, 2021 | 604,212.50 |
| Jun 30, 2021 | 634,542.00 |
| Mar 31, 2021 | 657,372.50 |
| Dec 30, 2020 | 715,676.00 |
| Sep 30, 2020 | 781,254.50 |
| Jun 30, 2020 | 848,410.50 |
| Mar 31, 2020 | 839,017.50 |
| Dec 31, 2019 | 835,955.50 |
| Sep 30, 2019 | 910,837.50 |
| Jun 30, 2019 | 973,110.50 |
| Mar 31, 2019 | 1.08 Mn |
| Dec 31, 2018 | 1.21 Mn |
| Sep 30, 2018 | 1.01 Mn |
| Jun 30, 2018 | 719,164.50 |
| Mar 31, 2018 | 626,284.00 |
| Dec 31, 2017 | 551,444.50 |
| Sep 30, 2017 | 241,583.50 |
| Jun 30, 2017 | -22,220.50 |
| Mar 31, 2017 | -19,241.50 |
| Dec 31, 2016 | -18,499.50 |
| Sep 30, 2016 | -11,729.50 |
| Jun 30, 2016 | -103.50 |